Wise Medical Advances Non-Invasive Brain-Computer Interface with R&D Investment Exceeding 15%

Recently,VISHEETechnological breakthroughs have been achieved in the field of non-invasive brain-computer interfaces, with core technologies such as high-precision EEG signal acquisition, environmental interference correction, neural feature extraction, and machine learning decoding algorithms now mastered, along with dozens of related patents.

After its listing in 2020, the company, with magnetic stimulation and electrical stimulation technologies as its core, efficiently utilized the funds raised for investment.Robot, as well as the research and innovation of emerging technologies such as lasers and radiofrequency. In the past three years, the proportion of R&D investment has steadily remained above 15%, placing it at a relatively high level within the industry. According to Tong Yihong, the company's Secretary of the Board, during overseas exhibitions, the inventor of Transcranial Magnetic Stimulation (TMS) technology showed strong interest in the company’s booth, reflecting international recognition of the company’s technological capabilities.

In 2009, VISHEE began to continuously invest in R&D, building core technology platforms such as electrical stimulation, magnetic stimulation, and electrophysiology, and launched several key products including pelvic floor functional magnetic stimulators. The company successively entered core sectors such as mental health rehabilitation, pelvic floor and postpartum rehabilitation, and neurological rehabilitation, forming a differentiated competitive advantage. However, as the company expanded, the market capacity of traditional businesses gradually revealed its ceiling, prompting the company to explore applying its foundational technologies to more treatment scenarios.

This technological expansion enables VISHEE to accelerate the deep integration of brain-computer interface technology with clinical rehabilitation scenarios, aiming to lead rehabilitative medicine into a new era of precision, intelligence, and personalization. With the strategic support from China's national initiatives on brain science and rehabilitative medicine, the company is actively exploring the medical aesthetics, urology, and international markets, extending its services from maternal rehabilitation to a diverse range of groups including the elderly and children.

This article is based on publicly available information and organized with the assistance of AI. It does not constitute investment advice.